Conference Calendar

November 26-30 - EFOST 2008: 5th Meeting of the European Federation of National Associations of Orthopaedic Traumatology

November 28-December 3 - The 2008 Greater New York Dental Meeting

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Orthopedic and Dental Industry News Complete Archive »

EMPI

Orthopedic News Roundup 10-Aug-06 BY HUYEN NGUYEN

Earnings: Biologics: Orthovita reported 2Q:06 product sales came in at $11.2 million, up 32% compared to 2Q:05. On a non-GAAP basis net loss for the quarter was $5.1 million, or a loss of $0.10 per share. The Company did not... more

Private Equity Firm to Buy Encore for $870mm BY JOHN MCCORMICK

After the market close on Friday, a unit of the mega-sized private equity firm Blackstone Group (not to be confused with the spine company) offered Encore Medical Corporation shareholders a 36% premium to take the company private. The enterprise valuation... more

Encore Medical to Buy Compex Technologies for $109 Million BY JOHN MCCORMICK

Encore Medical Corp. (nasdaq: ENMC) announced this morning that it is expanding its presence in the pain management business with the acquisition of Compex Technologies Inc. (nasdaq: CMPX)in an all-stock transaction valued at $109 million. Under the terms of the... more

Orthopedic News Roundup 5-Aug-05 BY HUYEN NGUYEN

This week we finish off the first half of 2005 reporting season with 17 orthopedic companies* released their financial numbers. In 2Q:05, in an aggregated total, orthopedic revenues increased 16% ($3.8 billion vs. $3.2 billion) and a 25% increased in... more

EMPI Files for IPO BY JOHN MCCORMICK

The IPO market for orthopedic and related companies is clearly heating up this year. Witness the recent offerings from NuVasive and dj Orthopedics. Now St. Paul, MN based orthopedic rehabilitation company EMPI, Inc. has just filed its Registration Statement with... more


Complete Archive

Reports

Introductory Guide to Intellectual Property for Medical Devices

Dr. Gary Michelson knows his patent rights. Medtronic made him a billionaire for it. Knowing the rules of intellectual property is just as important for any device firm. It's such a critical factor in firm valuations: affecting cash flow timelines, product development, partnering, and many other competitive factors. Purchase this report for $295 »

More Orthopedic Research Reports

Musculoskeletal Allograft in the US PURCHASE FOR $279 »
Group Purchasing Organizations & Market Reform PURCHASE FOR $379 »
Gainsharing 2006 PURCHASE FOR $179 »
FDA Approval for Orthopedic Devices PURCHASE FOR $179 »
Devices, Distribution and Dollars PURCHASE FOR $179 »
2005 Orthopedic Market Report: Sports Medicine PURCHASE FOR $179 »
Orthopedic Biomaterials 2005 PURCHASE FOR $179 »
Orthopedic Reimbursement 2005 PURCHASE FOR $179 »